Reading size

PACK IN HAND · ONE-PAGE CHECK

Medicine pack check sheet

Print this sheet or fill it in before speaking with a pharmacist or clinician. Copy only what is printed on the pack in hand. The published fields below are starting points from this record, not proof that your pack is the same product.

Published record starting point

Record display name
VIBRAMYCIN
Generic name / active ingredient
doxycycline
Dosage-form class
Dosage form and presentation as documented in the linked primary label
Route
Oral
Record reviewed
2026-08-28

Copy from the pack in hand

Source-linked reading points

  • 100 mg is the labelled amount per capsule; 25 mg/5 mL and 50 mg/5 mL are concentrations of two different liquid products. Do not self-convert, combine, substitute or assemble a course from these numbers.
  • The label warns about photosensitivity, oesophageal irritation or ulceration, severe skin reactions, intracranial hypertension and C. difficile-associated diarrhoea. Severe or rapidly worsening symptoms, breathing difficulty, swelling of the face/lips/tongue/throat, widespread rash or blisters, vision change, severe headache, or persistent/bloody diarrhoea require prompt local emergency or medical support.
  • The capsule/tablet label calls for adequate fluid to reduce oesophageal irritation and ulceration. If swallowing is difficult, the actual product differs or instructions are unclear, ask a pharmacist or prescriber to check the exact label first; do not open a capsule or switch to a historical liquid product yourself.
  • Antacids, iron/calcium/magnesium/aluminium products, other prescriptions and supplements belong on the complete medicine list for pharmacist review. The site does not generate co-use spacing from a name list and does not replace the prescription.

Reviewed presentation examples — compare every field

  • Equivalent to doxycycline 100 mg per capsule; 50-capsule bottleNDC 0069-0950-50
  • Doxycycline 25 mg per 5 mL after reconstitution; total volume 60 mLNDC 0069-0970-65
  • Doxycycline 50 mg per 5 mL; total volume 473 mLNDC 0069-0971-74

EDITORIAL RECORD

Who prepared and checked this page

Byline
OriginDrug Content Editorial
Review role
Public primary-source verification
Last reviewed
2026-08-28
Source record
2 clickable primary-source entry points are listed with this dossier.

The review role checks source traceability, stated market, document version and product-identity fields. It is not a claim of clinical licensure, prescribing authority or individual pharmacy service. Read the editorial policy.

Search records
Enlarged public-label image